Caption Management, LLC Amicus Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

$5.74 Billion
Q3 2024

Call Options

23 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$9.04 - $11.75 $1.24 Million - $1.61 Million	-136,900 Reduced 79.64%	35,000 $347,000
Q1 2024 May 15, 2024	BUY	$11.43 - $14.24 $193,167 - $240,656	16,900 Added 10.9%	171,900 $2.02 Million
Q4 2023 Feb 14, 2024	BUY	$9.97 - $14.52 $648,050 - $943,800	65,000 Added 72.22%	155,000 $2.2 Million
Q3 2023 Nov 14, 2023	BUY	$11.78 - $13.86 $117,800 - $138,600	10,000 Added 12.5%	90,000 $1.09 Million
Q2 2023 Aug 14, 2023	SELL	$10.72 - $13.3 $643,200 - $798,000	-60,000 Reduced 42.86%	80,000 $1 Million
Q1 2023 May 15, 2023	BUY	$10.91 - $13.54 $436,400 - $541,600	40,000 Added 40.0%	140,000 $1.55 Million
Q4 2022 Feb 14, 2023	BUY	$9.89 - $12.7 $989,000 - $1.27 Million	100,000 New	100,000 $1.22 Million
Q2 2022 Aug 15, 2022	BUY	$6.23 - $11.12 $1.36 Million - $2.44 Million	219,100 New	219,100 $2.35 Million
Q1 2022 May 13, 2022	SELL	$7.89 - $12.48 $3.92 Million - $6.2 Million	-496,400 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$9.82 - $12.44 $329,952 - $417,984	-33,600 Reduced 6.34%	496,400 $5.73 Million
Q3 2021 Nov 12, 2021	SELL	$8.74 - $11.84 $617,918 - $837,088	-70,700 Reduced 11.77%	530,000 $5.06 Million
Q2 2021 Aug 16, 2021	SELL	$8.71 - $10.72 $994,682 - $1.22 Million	-114,200 Reduced 15.97%	600,700 $5.79 Million
Q1 2021 May 17, 2021	BUY	$9.2 - $23.86 $3 Million - $7.78 Million	325,900 Added 83.78%	714,900 $7.06 Million
Q4 2020 Feb 16, 2021	BUY	$13.47 - $24.89 $1.19 Million - $2.19 Million	88,000 Added 29.24%	389,000 $8.98 Million
Q3 2020 Nov 16, 2020	BUY	$12.89 - $15.89 $2.01 Million - $2.48 Million	156,000 Added 107.59%	301,000 $4.25 Million
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $930,299 - $1.65 Million	105,000 Added 262.5%	145,000 $2.19 Million
Q1 2020 May 15, 2020	BUY	$6.63 - $11.16 $265,200 - $446,400	40,000 New	40,000 $370,000
Q4 2019 Feb 13, 2020	SELL	$7.48 - $10.75 $149,600 - $215,000	-20,000 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$8.02 - $13.25 $180,450 - $298,125	-22,500 Reduced 52.94%	20,000 $160,000
Q2 2019 Aug 13, 2019	SELL	$10.96 - $14.4 $88,776 - $116,640	-8,100 Reduced 16.01%	42,500 $530,000
Q1 2019 May 14, 2019	BUY	$10.04 - $13.92 $508,023 - $704,352	50,600 New	50,600 $689,000
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $1.31 Million - $1.71 Million	-100,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$12.51 - $16.24 $1.25 Million - $1.62 Million	100,000	100,000 $1.44 Million

Others Institutions Holding FOLD

# of Institutions

311

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

Vanguard Group Inc Valley Forge, PA

28.8M
Shares

$260 Million
0.01% of portfolio
Perceptive Advisors LLC New York, NY

28.1M
Shares

$253 Million
7.83% of portfolio
Black Rock Inc. New York, NY

24.4M
Shares

$220 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

24M
Shares

$216 Million
0.05% of portfolio
Avoro Capital Advisors LLC New York, NY

23.2M
Shares

$209 Million
3.72% of portfolio

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account